CN107337649B — 一种乙酸钠水合物无定型及其制备方法和用途
Assigned to Guangxi Kelun Pharmaceutical Co Ltd · Expires 2020-10-16 · 6y expired
What this patent protects
本申请涉及药物化学领域,具体涉及一种乙酸钠水合物无定型及其制备方法和用途。本申请的无定型相对于晶型具有更高的稳定性,更利于储存和运输保存,更易于进行制剂的工艺操作;并且本申请的无定型分散度更好,易于加工,有利于2‑(5‑溴‑4‑(4‑环丙基萘‑1‑基)‑4H‑1,2,4‑三唑‑3‑基硫基)乙酸钠(式I)作为药品有效成分的溶出以及其生物利用度的提高,有益于降低药品的使用剂量从而减小药品的毒性,
USPTO Abstract
本申请涉及药物化学领域,具体涉及一种乙酸钠水合物无定型及其制备方法和用途。本申请的无定型相对于晶型具有更高的稳定性,更利于储存和运输保存,更易于进行制剂的工艺操作;并且本申请的无定型分散度更好,易于加工,有利于2‑(5‑溴‑4‑(4‑环丙基萘‑1‑基)‑4H‑1,2,4‑三唑‑3‑基硫基)乙酸钠(式I)作为药品有效成分的溶出以及其生物利用度的提高,有益于降低药品的使用剂量从而减小药品的毒性,
Drugs covered by this patent
- Aloprim (ALLOPURINOL) · Casper Pharma Llc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.